Debt-to-equity of Guardion Health Sciences, Inc. from 30 Sep 2019 to 30 Jun 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Guardion Health Sciences, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2019 to 30 Jun 2024.
  • Guardion Health Sciences, Inc. Debt-to-equity for the quarter ending 30 Jun 2024 was 53%, a 14% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Guardion Health Sciences, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2024 53% -9% -14% 30 Jun 2024
Q1 2024 84% +35% +71% 31 Mar 2024
Q4 2023 67% +14% +27% 31 Dec 2023
Q3 2023 83% +48% +137% 30 Sep 2023
Q2 2023 62% +37% +152% 30 Jun 2023
Q1 2023 49% +33% +210% 31 Mar 2023
Q4 2022 53% +48% +1077% 31 Dec 2022
Q3 2022 35% +30% +583% 30 Sep 2022
Q2 2022 24% +19% +313% 30 Jun 2022
Q1 2022 16% +9% +122% 31 Mar 2022
Q4 2021 4% -8% -64% 31 Dec 2021
Q3 2021 5% -5% -52% 30 Sep 2021
Q2 2021 6% -4% -41% 30 Jun 2021
Q1 2021 7% -4% -36% 31 Mar 2021
Q4 2020 12% -6% -31% 31 Dec 2020
Q3 2020 11% -15% -58% 30 Sep 2020
Q2 2020 10% 30 Jun 2020
Q1 2020 11% 31 Mar 2020
Q4 2019 18% 31 Dec 2019
Q3 2019 25% 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.